Historical regulatory context
The original article discussed the FDA’s May 2024 laboratory-developed-test rule and the legal challenges then underway. Its anticipated compliance dates and regulatory expectations belong to that publication context and are not presented here as current legal requirements.
A durable planning lesson
When oversight changes, laboratories need visibility into affected tests, quality processes, documentation, resources, and decision responsibilities. A structured assessment helps distinguish immediate obligations from assumptions and identify work that can be sequenced. Cross-functional governance connects scientific, quality, regulatory, and operating teams so an organization can respond coherently as requirements evolve. The central management principle is readiness built on verified requirements.